System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Mario Clerici, MD, PhD is an expert in Immunology at Don Carlo Gnocchi Foundation (Italy). As of October 2026, ScienceLeadR ranks Mario Clerici in the top 1% of experts worldwide for HIV Infections, Immunologic Deficiency Syndromes and Sexually Transmitted Diseases. Mario Clerici has authored 837 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 4 of them ongoing. SLR score: 2,859 (community average: 125). How the SLR is computed.

LeadR Profile

Mario Clerici, MD, PhD Don Carlo Gnocchi Foundation Italy
2 859 ScienceLeadR Reputation 2859

Unlock

Register Login
Network Map

Immunology

Subspecialties: Biochemistry - Infectiology - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1987 - 2026
Source: PubMed

University of Milan

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 837

Citations

Citations: 44 012 1st author: 88 Last author: 284 Unique author: 11

Main journals

AIDS 57
J Immunol 24
J Infect Dis 24
Front Immunol 23
Sci Rep 23

Best Journals

Science 9
Lancet 3
N Engl J Med 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The silent infection load: How lifelong asymptomatic infections may contribute to inflammaging as an evolutionary trade-off of longevity.
PMID 42692089 — asymptomatic infections, aging, longevity, infections		Ageing Res Rev20261
Oligomeric Alpha-Synuclein from neural-derived extracellular vesicles as possible biomarkers of non-motor symptoms in Parkinson's disease.
PMID 42649220 — extracellular vesicles, serum, parkinson disease, biomarkers, signs and symptoms, alpha-synuclein, synucleins		NPJ Parkinsons Dis20260
Mucosal and systemic immune signatures reveal compartmentalized regulation of gut barrier integrity in virologically suppressed HIV Infection.
PMID 42528924 — biopsy, biomarkers, hiv, immune system diseases, hiv infections, infections		Front Immunol20260
IL-1 polymorphisms modulates functional recovery following rehabilitation in multiple sclerosis.
PMID 42454040 — sclerosis, genes, multiple sclerosis, immunogenetics, genetics, rehabilitation, recycling, work, interleukin-1, alleles		Front Immunol20260
Irisin in the aging immune landscape: a new player at the crossroads of immunosenescence and sepsis.
PMID 42425420 — muscles, aging, cellular senescence, immunosenescence, biomarkers, sepsis		Ageing Res Rev20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1

By phase:

N/A 6
Phase 3 1

By status:

Not yet recruiting 2
Unknown 2
Active not recruiting 1
Completed 1
Recruiting 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
New Diagnostic Approaches in the Management of Inflammatory Lung Diseases
NCT07723638 — environmental exposure, diagnosis, differential, idiopathic pulmonary fibrosis, disease management, chronic disease, lung, fibrosis, pharmaceutical preparations, multiple chronic conditions, telemedicine, inhalation, biomarkers, pulmonary disease, chronic obstructive, pulmonary fibrosis, precision medicine, diagnosis, therapeutics, lung diseases, lung diseases, obstructive, environmental monitoring, medical devices		N/ANot yet recruiting2026
Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia
NCT07707245 — idiopathic pulmonary fibrosis, chronic disease, lung, blood, serum, fibrosis, micrornas, smokers, emphysema, neoplasms, biomarkers, pulmonary disease, chronic obstructive, lung neoplasms, pulmonary fibrosis, lung diseases, dna, lung diseases, obstructive		N/ARecruiting2026
The Role of Immune Checkpoints in Lung Transplant (ILTRA)
NCT06302556 — graft rejection, lymphocyte activation, cells, genes, mucins, lung, cyclooxygenase 2, interleukin-7, lymphocytes, bronchoalveolar lavage, interleukin-6, interleukin-8, rna, messenger, immunoglobulins, transplants, therapeutics, immune checkpoint proteins, t-lymphocytes, interleukin-18, lung transplantation, ligands, allografts, transplantation, interleukin-10, gene expression, rna		N/ANot yet recruiting2024
HEBE Project Healthy Aging Versus Inflamm aging the Role of Physical Exercise in Modulating the Biomarkers of Age associated and Environmentally Determined Chronic Diseases
NCT05815732 — exercise, chronic disease, life style, aging, biomarkers, research, healthy aging		N/AActive not recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS